Fri, April 26, 2024
Thu, April 25, 2024
Wed, April 24, 2024

Stephen Brozak Maintained (CDTX) at Strong Buy and Held Target at $40 on, Apr 25th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-40-on-apr-25th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Stephen Brozak of WBB Securities, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $40 on, Apr 25th, 2024.

Stephen has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Stephen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Stephen


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $120 on, Monday, April 8th, 2024

Publication Contributing Sources